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Items for this week’s Epi Update include: 
 Chlamydia and gonorrhea cases continue to increase in Iowa 
 CDC, ACIP update Japanese encephalitis vaccination guidelines 
 World Hepatitis Day - July 28th   
 Program area spotlight: Hospital associated infections (HAI) 
 In the news: What tick saliva does to the human body 
 In the news: Simple ways to prevent falls in older adults 
 In the news: Exposure to nature could help fight junk food cravings 
 Infographic: Clinicians - Timing is key for AFM 
 
Chlamydia and gonorrhea cases continue to increase in Iowa 
Preliminary data for 2019 indicate a continued increase in two of the most commonly reported 
conditions in Iowa, chlamydia and gonorrhea. For the period of January 1, 2019 through June 
30, 2019, there were 7,730 cases of chlamydia reported to IDPH. This represents a 9.6 
percent increase from the same time period in 2018. Gonorrhea cases for this time period in 
2019 are at 2,572. This represents a 14.6 percent increase compared to the same period in 
2018. 
 
IDPH encourages adherence to CDC screening and treatment guidelines to ensure that 
individuals who are infected are diagnosed and properly treated. 
https://www.cdc.gov/std/treatment/default.htm 
   
CDC, ACIP update Japanese encephalitis vaccination guidelines 
Japanese encephalitis, a mosquitoborne flavivirus, occurs throughout most of Asia and parts of 
the western Pacific. Approximately 20-30 percent of patients die, and 30-50 percent of 
survivors have long-term sequelae. No antiviral treatment is available.  
 
All travelers to countries where Japanese encephalitis is endemic should be advised to take 
precautions to avoid mosquito bites. Most travelers to endemic countries are at very low risk 
for Japanese encephalitis. Factors that increase risk include: 
 traveling for a longer period (e.g., ≥1 month) 
 travel during the JE virus transmission season 
 spending time in rural areas 
 participating in extensive outdoor activities 
 staying in accommodations without air conditioning, screens, or bed nets.  
 
Inactivated Vero cell culture–derived vaccine (Ixiaro [JE-VC]) is the only licensed Japanese 
encephalitis vaccine available in the U.S. and is licensed for use in persons aged ≥2 months. 
The decision about whether to vaccinate for Japanese encephalitis should be individualized 
and consider:  
 the risks related to the specific travel itinerary 
 the likelihood of future travel to endemic countries 
 the high morbidity and mortality of Japanese encephalitis 
 the availability of an effective vaccine 
 the possibility (but low probability) of serious adverse events after vaccination 
 the traveler’s personal perception and tolerance of risk. 
 
Japanese encephalitis vaccine is not recommended for travelers at low risk, such as shorter-
term travel to urban areas or outside of Japanese encephalitis virus transmission season. 
 
For full recommendations, visit 
www.cdc.gov/mmwr/volumes/68/rr/rr6802a1.htm?s_cid=rr6802a1_e&deliveryName=USCDC_
921-DM4987. 
 
World Hepatitis Day - July 28th  
An estimated 257 million people live with chronic hepatitis B and 71 million people live with 
chronic hepatitis C worldwide. Viral hepatitis causes more than one million deaths globally 
each year.  Hepatitis A, hepatitis B, and hepatitis C are the most common types of viral 
hepatitis in the United States. 
 
An online hepatitis risk assessment has been developed (based on CDC recommendations for 
the United States) which will provide individualized recommendations for testing and/or 
vaccination for hepatitis A, B, or C. To access the assessment visit: 
https://www.cdc.gov/hepatitis/riskassessment/index.htm 
 
Program area spotlight: Hospital associated infections (HAI) 
The HAI team at IDPH is dedicated to reducing the risk for healthcare associated infections 
and multi-drug resistant organisms. The team leads outbreak response investigations, which 
include infections caused by antibiotic resistant pathogens. Carbapenem-resistant 
Enterobacteriaceae (CRE) was made a reportable condition in 2017, and 30 reported CRE 
cases were investigated in 2018. The HAI team has also partnered with the Iowa Hospital 
Association and the Iowa Healthcare Collaborative to promote antibiotic stewardship practices.  
 
The team conducts infection prevention consultations in health care settings utilizing the CDC 
Infection Control Assessment and Response (ICAR) tool. To date, 249 ICAR consultations 
have been conducted at hospitals, long-term care facilities, and outpatient facilities across the 
state. Education and training for healthcare professionals is provided via the annual Iowa 
Infection Prevention and Control Conference, regional meetings, and in-person training for 
long-term care and acute care infection preventionists. 
 
Data from the National Healthcare Safety Network, CDC, and healthcare partners such as 
Iowa Department of Inspections and Appeals is used to focus prevention efforts. 
 
For more infarction about the HAI team, visit idph.iowa.gov/hai-prevention.  
 
In the news: What tick saliva does to the human body 
www.theatlantic.com/science/archive/2019/07/the-marvels-of-tick-saliva/594652/  
 
In the news: Simple ways to prevent falls in older adults 
www.npr.org/sections/health-shots/2019/07/14/741310765/simple-ways-to-prevent-falls-in-
older-adults  
 
In the news: Exposure to nature could help fight junk food cravings 
www.newsweek.com/junk-food-smoking-craving-nature-1450277  
 
Infographic: Clinicians - Timing is key for AFM 
 
 
To view in full size, visit www.cdc.gov/vitalsigns/afm/index.html.  
 
Have a healthy and happy week! 
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800-362-2736 
